noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

University of Cincinnati

Cincinnati CIO Roundtable and UC's School of Information Technology[...]
University of Cincinnati

Using GLP-1s for weight loss, maintenance after bariatric surgery
University of Cincinnati

New football helmets perform better in concussion testing

International News

Taft Stettinius & Hollister LLP

01/23/2025 | Press release | Distributed by Public on 01/23/2025 13:56

Taft Acted as Legal Counsel to Nimble Therapeutics in Sale to AbbVie

Taft is pleased to have acted as legal counsel to Nimble Therapeutics in its sale to AbbVie (NYSE: ABBV). Nimble is a biotechnology company dedicated to delivering on the promise of oral peptide therapeutics. AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. Read the release here.

Taft's core deal team was led by Sara Kruse and included Josh Borson, Marko Belej, Jeanne Cors, Chris Fowler, Bridget Tignanelli, Nick Binder, Aaron Miller, and Summer Moukalled.

Taft Stettinius & Hollister LLP published this content on January 23, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on January 23, 2025 at 19:56 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]

Back

View original format